Escitalopram
Prescription ·Exploratory record · not publication-reviewed ·Updated July 13, 2026
Prescription selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder and generalized anxiety disorder. The S-enantiomer of citalopram, it is considered one of the most selective SSRIs with a favorable tolerability profile. Frequently cited as the most effective and acceptable antidepressant in network meta-analyses. Dosage must be determined by your prescribing physician.
Exploratory record, not a reviewed medical publication.
See the editorial and medical-review policies for the publication gate.
This generated database record has not completed a claim-level review by a qualified human medical reviewer. Bibliography links and evidence labels are not approval. The page remains available for reference and is excluded from search indexing.
What the research says.
A quick, data-only summary. The full evidence, dosing, and sources are below.
Prescription selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder and generalized anxiety disorder. NutriStack rates the supporting evidence as strong. Common adult dosing is 5–20 mg daily (as prescribed by your physician), though a prescriber sets the actual dose. With long-term use it can deplete sodium, folate. This profile indexes 10 sources.
The bottom line
Evidence rating strong. Most-documented uses: depression symptom relief, generalized anxiety reduction, improved emotional regulation. 10 sources indexed (2009–2025), with 0 interaction records on file.
How it works, mechanistically.
Core mechanism
Selectively inhibits the reuptake of serotonin (5-HT) by blocking the serotonin transporter (SERT). As the active S-enantiomer of citalopram, it binds to both the primary and allosteric sites of SERT with high selectivity.
Dosing & protocol.
Can be taken with or without food. May be taken morning or evening.
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Sodium
SignificantSSRI-induced SIADH can lower serum sodium, especially in older adults and during the first weeks of therapy.
Folate
MildLower folate status is associated with poorer SSRI response and may be reduced in some chronic users through altered one-carbon metabolism.
Full safety detail.
Sources, by evidence tier.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
4- 1Escitalopram and functional connectivity in major depressive disorder: A systematic reviewPMIDTuriaco F, Arnone F, Drago A et al. · Journal of psychopharmacology (Oxford, England) · 2025
Turiaco F, Arnone F, Drago A et al.. Escitalopram and functional connectivity in major depressive disorder: A systematic review. Journal of psychopharmacology (Oxford, England). 2025
- 2Comparative oral monotherapy of psilocybin, lysergic acid diethylamide, 3,4-methylenedioxymethamphetamine, ayahuasca, and escitalopram for depressive symptoms: systematic review and Bayesian network meta-analysisPMIDHsu TW, Tsai CK, Kao YC, Thompson T et al. · BMJ · 2024
Escitalopram remained comparable to several psychedelic compounds for depression treatment, with escitalopram having the most established long-term safety and efficacy data
- 3Efficacy of escitalopram for poststroke depression: a systematic review and meta-analysisPMIDFeng RF, Ma R, Wang P et al. · Scientific reports · 2022
Feng RF, Ma R, Wang P et al.. Efficacy of escitalopram for poststroke depression: a systematic review and meta-analysis. Scientific reports. 2022
- 4Escitalopram in the treatment of major depressive disorder: a meta-analysisPMIDKennedy SH, Andersen HF, Thase ME · Current medical research and opinion · 2009
Kennedy SH, Andersen HF, Thase ME. Escitalopram in the treatment of major depressive disorder: a meta-analysis. Current medical research and opinion. 2009
Randomized controlled trials
2- 5Efficacy and Safety of Hormone Replacement Combined With Escitalopram in the Treatment of Chronic Insomnia in Perimenopausal Women: A Randomized Controlled TrialPMIDChen H, Wu S, Chen H et al. · CNS neuroscience & therapeutics · 2025
Chen H, Wu S, Chen H et al.. Efficacy and Safety of Hormone Replacement Combined With Escitalopram in the Treatment of Chronic Insomnia in Perimenopausal Women: A Randomized Controlled Trial. CNS neuroscience & therapeutics. 2025
- 6Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trialPMIDRajji TK, Baksh SN, Shade DM et al. · Nature medicine · 2025
Rajji TK, Baksh SN, Shade DM et al.. Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial. Nature medicine. 2025
Reference material
4- 7Cipriani A et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018.Source linkedPMID
- 8Baldwin DS et al. Efficacy of escitalopram in the treatment of social anxiety disorder. Br J Psychiatry. 2009.Source linkedPMID
- 9Kamel MA et al. Effect of antidepressants on motor and functional recovery in stroke: a systematic review and meta-analysis. BMC Neurol. 2026.Source linkedPMID
- 10Yin J, Song X, Wang C et al.. Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis. BMC psychiatry. 2023Source linkedPMID
Common questions.
Quick answers about Escitalopram, drawn from the data on this page.
What is Escitalopram?
Prescription selective serotonin reuptake inhibitor (SSRI) approved for major depressive disorder and generalized anxiety disorder. The S-enantiomer of citalopram, it is considered one of the most selective SSRIs with a favorable tolerability profile. Frequently cited as the most effective and acceptable antidepressant in network meta-analyses. Dosage must be determined by your prescribing physician.
What is Escitalopram used for?
Commonly cited benefits of Escitalopram include: Depression symptom relief; Generalized anxiety reduction; Improved emotional regulation; Favorable tolerability; Social anxiety improvement. NutriStack rates the overall evidence as strong.
What is a typical dose of Escitalopram?
A typical adult dose of Escitalopram is 5–20 mg daily (as prescribed by your physician). The commonly recommended form is Tablet or oral solution. These are general ranges, not personalized advice; confirm the right dose with a clinician.
What are the side effects of Escitalopram?
Reported side effects include nausea, insomnia, sexual dysfunction, headache, diarrhea, drowsiness. This is educational information; check with a healthcare professional before use.
How strong is the evidence for Escitalopram?
NutriStack rates this as Strong, meaning multiple high-quality meta-analyses or systematic reviews converge on the same finding. Full tier criteria are at https://nutristackapp.com/methodology/evidence-tiers.
Use this with your stack
Escitalopram in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.